Anti-B4GT1/ B4GALT1/ B4GAL-T1 monoclonal antibody

Anti-B4GT1/ B4GALT1/ B4GAL-T1 antibody for FACS & in-vivo assay

Target products collectionGo to B4GALT1/B4GALT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0129-Ab-1/ GM-Tg-hg-MP0129-Ab-2Anti-Human B4GALT1 monoclonal antibodyHuman
GM-Tg-rg-MP0129-Ab-1/ GM-Tg-rg-MP0129-Ab-2Anti-Rat B4GALT1 monoclonal antibodyRat
GM-Tg-mg-MP0129-Ab-1/ GM-Tg-mg-MP0129-Ab-2Anti-Mouse B4GALT1 monoclonal antibodyMouse
GM-Tg-cynog-MP0129-Ab-1/ GM-Tg-cynog-MP0129-Ab-2Anti-Cynomolgus/ Rhesus macaque B4GALT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0129-Ab-1/ GM-Tg-felg-MP0129-Ab-2Anti-Feline B4GALT1 monoclonal antibodyFeline
GM-Tg-cang-MP0129-Ab-1/ GM-Tg-cang-MP0129-Ab-2Anti-Canine B4GALT1 monoclonal antibodyCanine
GM-Tg-bovg-MP0129-Ab-1/ GM-Tg-bovg-MP0129-Ab-2Anti-Bovine B4GALT1 monoclonal antibodyBovine
GM-Tg-equg-MP0129-Ab-1/ GM-Tg-equg-MP0129-Ab-2Anti-Equine B4GALT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0129-Ab-1/ GM-Tg-hg-MP0129-Ab-2; GM-Tg-rg-MP0129-Ab-1/ GM-Tg-rg-MP0129-Ab-2;
GM-Tg-mg-MP0129-Ab-1/ GM-Tg-mg-MP0129-Ab-2; GM-Tg-cynog-MP0129-Ab-1/ GM-Tg-cynog-MP0129-Ab-2;
GM-Tg-felg-MP0129-Ab-1/ GM-Tg-felg-MP0129-Ab-2; GM-Tg-cang-MP0129-Ab-1/ GM-Tg-cang-MP0129-Ab-2;
GM-Tg-bovg-MP0129-Ab-1/ GM-Tg-bovg-MP0129-Ab-2; GM-Tg-equg-MP0129-Ab-1/ GM-Tg-equg-MP0129-Ab-2
Products NameAnti-B4GALT1 monoclonal antibody
Formatmab
Target NameB4GALT1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-B4GALT1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species B4GT1/ B4GALT1/ B4GAL-T1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP0023660 B4GALT1 Lentivirus particle
    ORF Viral VectorpGMLP002366human B4GALT1 Lentivirus plasmid
    ORF Viral VectorpGMLPm002325mouse B4galt1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002325mouse B4galt1 Lentivirus particle


    Target information

    Target IDGM-MP0129
    Target NameB4GALT1
    Gene ID2683,14595,24390,703541,481579,101100927,281781,100068209
    Gene Symbol and Synonyms4-GalT,4-GalT1,B-1,B4GAL-T1,B4GALT1,beta-1,beta4Gal-T1,CDG2D,CLDLFIB,GalT,Ggtb,GGTB2,GT1,GTB
    Uniprot AccessionP15291,P80225,P08037
    Uniprot Entry NameB4GT1_HUMAN,B4GT1_RAT,B4GT1_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000086062
    Target ClassificationN/A

    The target: B4GALT1, gene name: B4GALT1, also named as B4GAL-T1, CDG2D, GGTB2, GT1, GTB, beta4Gal-T1. This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.